Biotechnology

Biotechnology

At Seed IP, we work with a wide range of clients on cutting-edge innovations for the health care industry. We understand patenting biotechnology advancements requires significant scientific knowledge. Our professionals, many with advanced degrees, know the technology and the industry. Immunology, molecular biology, biochemistry, and protein biology are only a few examples of our breadth of expertise. Our professionals combine impressive scientific credentials with in-depth knowledge of intellectual property law to shape strong, value-maximizing protection for our clients’ ideas and inventions.

Our biotechnology expertise:

  • Molecular biology and genetics
  • Biochemistry
  • Microbiology
  • Immunology
  • Cell biology
  • Neuroscience
  • Pharmacology
  • Structural biology
  • Protein biology
  • Bioinformatics
  • Nanotechnology
  • Pharmaceuticals
  • Plant biology
  • Medical devices


Biotechnology

Professionals

Anna L. Mallam, Ph.D.

Senior Patent Agent

Patent Agent

Anna L. Mallam, Ph.D.

Anna's practice focuses on U.S. and foreign biotechnology and pharmaceutical patent matters including patent preparation and prosecution, as well as freedom-to-operate and patentability analyses.

She received a Ph.D. (2007) in Biophysics from the University of Cambridge, UK. Anna also earned an M.S. (2003) in Chemistry (first class) and a B.S. (2002) in Chemistry (first class), both from the University of Cambridge, UK.

Christopher D. Bayne

Senior Associate

Senior Associate

Christopher D. Bayne

Christopher has over 13 years of experience as a patent professional representing clients primarily in pharmaceutical, biotechnology and material technology sectors. He focuses his practice on patent preparation and prosecution, global portfolio strategy and management, and providing legal opinions. In 1996, Chris received his M.S. in Chemistry from the Massachusetts Institute of Technology, where his research focused on the design and synthesis of self-complimentary molecules capable of molecular self-assembly. Chris also practiced as a business litigator in Honolulu, Hawaii, upon receiving his J.D. from the William S. Richardson School of Law, University of Hawai´i (Mānoa) in 2009. He received a B.S. in Chemistry from California State University in 1994. Chris served in the United States Navy as a nuclear propulsion plant operator aboard an Ohio-class submarine.

Eric A. Harwood, Ph.D.

Partner

Partner

Eric A. Harwood, Ph.D.

Eric Harwood is the Chair of Seed’s Chemistry and Biotechnology Group. His practice focuses on chemical, pharmaceutical, and life science patent prosecution, strategy, and diligence matters. Eric earned a B.S. in Chemistry from the University of California at Davis (summa cum laude), and M.S. and Ph.D. degrees in Organic Chemistry from the University of Washington in Seattle. He received a J.D. from the University of Washington School of Law, where he now serves as an Adjunct Professor.

Biotechnology, Chemistry, Medical Devices, Pharmaceuticals
Patent, Strategic Counseling, Trade Secrets
Hai Han, Ph.D.

Partner

Partner

Hai Han, Ph.D.

Hai Han focuses her practice on U.S. and foreign chemical and pharmaceutical patent matters with a special emphasis on small molecules.

Alternative Energy, Biotechnology, Chemistry, Electrical Engineering, Electronics & Semiconductors, Medical Devices, Nanotechnology, Pharmaceuticals
IP Litigation & Enforcement, Patent, Strategic Counseling, Trade Secrets
Janaki Purushe, Ph.D.

Patent Agent

Patent Agent

Janaki Purushe, Ph.D.

Janaki focuses her practice on patent preparation and prosecution of biotechnology and pharmaceutical matters. She received her Ph.D. in Microbiology and Immunology from Temple University School of Medicine in 2018 and a B.S. in Cell Biology and Molecular Genetics from the University of Maryland in 2007.

Biotechnology, Pharmaceuticals
Patent
Jessica S. Gritton

Of Counsel

Of Counsel

Jessica S. Gritton

Jessica is an experienced IP attorney with a broad technical background in both the physical and life sciences. She is experienced in all phases of patent portfolio management with particular expertise in the assessment of patent portfolio strengths and weaknesses, technology transactions, and patent disputes within the pharmaceutical industry. Jessica received an M.S. in Biology from Massachusetts Institute of Technology in 2006, and a B.S. in Physics from University of Utah in 2002.She received her J.D. from Harvard Law School in 2010.

John A. Morgan

Partner

Partner

John A. Morgan

Keenly interested in the confluence of law, science, and business, John advises biotechnology companies, non-profit research institutions, investors, and universities on intellectual property matters for a variety of complex technologies, including therapeutic antibodies and fusion proteins, cell and gene therapies, vaccines, antisense therapies, engineered microorganisms, biologics manufacturing, and diagnostics.   

In his practice, John works to align intellectual property strategies with his clients’ technology and business objectives. He applies his natural curiosity, attention to detail, and creativity to patent counseling, drafting, and worldwide prosecution; life cycle management; patent landscape and freedom-to-operate analysis; and IP due diligence.

John has supported innovations for cancer and a variety of other diseases (infectious, neurodegenerative, lysosomal storage, autoimmune, genetic), as well as cellular agriculture. His passion for science stems from his time as a researcher at the Fred Hutchinson Cancer Center in Seattle, where he studied cell signaling and tissue patterning in the developing vertebrate brain, as well as cell growth genes in an invertebrate model. John appreciates supporting his clients’ efforts to improve human health and sustainable practices. He also has experience in the chemical and mechanical arts.

 John received his J.D. summa cum laude from Seattle University School of Law (2014) and his B.S. from the University of Puget Sound.

Biotechnology, Pharmaceuticals
Patent, Strategic Counseling, Trade Secrets
Michael P. Cooper

Partner

Partner

Michael P. Cooper

Michael's practice is focused on U.S. and foreign patent prosecution of chemistry and biotechnology matters, and related litigation matters.

Alternative Energy, Biotechnology, Chemistry, Pharmaceuticals
IP Agreements & Licensing, Patent, Strategic Counseling, Trade Secrets
Michelle M. LeCointe

Partner

Partner

Michelle M. LeCointe

Michelle LeCointe's practice centers on U.S. and international IP strategies and patent procurement as well as IP agreements for a broad array of technologies, with a focus on pharmaceuticals, biologics, medical devices, and rechargeable batteries. She also has substantial experience in corporate IP due diligence, U.S. and international post-grant contested proceedings, non-infringement and invalidity opinions, and patent litigation.

Michelle received a B.A. (magna cum laude) in Biochemical Sciences from Harvard University, in 1997. She received her J.D. from Columbia Law School, as a Harlan Fiske Stone Scholar, in 2000.

Qing (Becky) Lin, Ph.D.

Partner

Partner

Qing (Becky) Lin, Ph.D.

Becky helps biotechnology and pharmaceutical companies (including U.S., European and Chinese companies) obtain strategic patent protection for their technologies, minimize patent infringement risks, and facilitate their IP-related business transactions. She drafts and prosecutes patent applications related to various technologies, such as immunotherapeutics, proteins, genes, small molecules, pharmaceutical compositions, disease diagnosis and treatment, nucleic acid analysis, medical devices, and transgenic animals and plants. Becky also provides patentability, validity, freedom to operate, and non-infringement analyses and opinions in these areas.

Biotechnology, Medical Devices, Pharmaceuticals
Patent, Strategic Counseling, Trade Secrets
Shi (Michelle) Liu, Ph.D.

Senior Associate

Senior Associate

Shi (Michelle) Liu, Ph.D.

Michelle's practice is focused on patent procurement, licensing, and strategic intellectual property portfolio management in electrical and chemical matters.

Examples of expertise include semiconductors, materials science, batteries, electronics, optoelectronics, medical devices, nanotechnology, polymers, organic chemistry, pharmaceuticals, and cosmetics. Michelle has successfully drafted and prosecuted numerous patent applications of U.S. and international patent matters for clients ranging from small startups to large global corporations.

She received a B.S. in Polymer Chemistry from Sichuan University (1992), an M.S. in Polymer Chemistry and Physics from Jilin University (1995), a second M.S. in Organic Chemistry from Northeastern University (1999), and a Ph.D. in Materials Science & Engineering/Nanotechnology from University of Washington (2003). Michelle holds a J.D. from the University of Washington School of Law (2011).

Alternative Energy,Biotechnology,Chemistry,Electrical Engineering,Electronics & Semiconductors,Medical Devices,Nanotechnology,Pharmaceuticals
IP Litigation & Enforcement, Patent, Strategic Counseling, Trade Secrets
Tessa McClure

Patent Agent

Patent Agent

Tessa McClure

Tessa focuses her practice on U.S. patent prosecution in the life sciences sector and electrical engineering. She earned a B.S. in Biology from the University of Washington in 2014.

Toby J. Ligon

Senior Associate

Senior Associate

Toby J. Ligon

Toby specializes in patent prosecution of chemistry, biotechnology, and pharmaceutical matters. Toby received his B.S. (2007) and M.S. (2009) degrees, both in Chemistry, from Western Washington University. Toby received his J.D. cum laude from Seattle University School of Law in 2016, where he was honored with the Presidential Scholarship Award and the Washington State Bar Association Intellectual Property Scholarship Award, and made the Dean’s List.

Will de van der Schueren

Associate

Associate

Will de van der Schueren

Will’s practice focuses on patent prosecution, freedom-to-operate analysis, and due diligence in the life sciences sector. He earned a B.S. in Biochemistry from the University of Washington in 2012. Will received his J.D. from the University of Washington School of Law in 2023, with a Concentration Track in Intellectual Property.

Related NEWS Articles
News & Events
Team News
https://cdn.prod.website-files.com/5f15f11facaf57517589d0e3/640a897045cbed4ef640c567_Seed_IP_Media_Library_Biotechnology_1.webp
John A. Morgan

Seed IP partners Dr. Qing (Becky) Lin and John Morgan to attend 2024 BIO International Convention | San Diego, June 3-6

News & Events
Team News
https://cdn.prod.website-files.com/5f15f11facaf57517589d0e3/644899335920140dd2765a65_Seed_IP_Media_Library_Biotechnology_2.png
Qing (Becky) Lin, Ph.D.

Seed IP partner Dr. Qing (Becky) Lin to attend 2023 BIO International Convention in Boston – June 5-8

News & Events
https://cdn.prod.website-files.com/5f15f11facaf57517589d0e3/640a897045cbed4ef640c567_Seed_IP_Media_Library_Biotechnology_1.webp

Seed IP sponsors Life Science Innovation Northwest 2023 conference – April 25/26

Team News
https://cdn.prod.website-files.com/5f15f11facaf57517589d0e3/625223806a9c27cb150fcf64_Seed_IP_Media_Library_Biotechnology_2-%20BW.webp
Tessa McClure

Seed IP Law Group welcomes patent agent Tessa McClure